Our results indicate that female mice are protected from age‐related obesity and insulin resistance, and that unlike diet‐induced obesity, MitoQ does not reduce adiposity or improve insulin action in AG mice. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.